У нас вы можете посмотреть бесплатно Phenylketonuria vs Alkaptonuria | Causes, Symptoms & Biochemical Basis или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Phenylketonuria (PKU) and Alkaptonuria | Complete Breakdown of Amino Acid Metabolism Disorders Welcome to our detailed exploration of Phenylketonuria (PKU) and Alkaptonuria, two classic examples of inborn errors of metabolism that arise due to disruptions in the phenylalanine and tyrosine degradation pathways. These genetic disorders may be rare, but they hold profound importance in both biochemistry and clinical medicine. In this video, we guide you through the biochemical mechanisms, genetic mutations, clinical presentations, and management of these two conditions. Using clear visuals and simplified explanations, we connect the dots between enzymatic deficiencies and their systemic effects. 🔍 What You Will Learn: 🔹 Phenylketonuria (PKU): Caused by a deficiency of the enzyme phenylalanine hydroxylase Leads to the accumulation of phenylalanine, which is toxic to the developing brain Symptoms include intellectual disability, microcephaly, seizures, hypopigmentation, and a musty odor of the urine Importance of newborn screening and early dietary phenylalanine restriction Role of tetrahydrobiopterin (BH4) in some cases (mild/malignant PKU) 🔹 Alkaptonuria: Results from a mutation in the HGD gene, causing a deficiency of homogentisate oxidase Leads to the buildup of homogentisic acid (HGA), which oxidizes and polymerizes into a dark pigment Classic features: dark urine, ochronosis (bluish-black pigmentation of connective tissues), and early-onset arthritis Slow-progressing but often not detected until adulthood Current treatment is largely supportive, with research ongoing into nitisinone therapy to block upstream accumulation 🔄 Comparison and Clinical Significance: We compare both disorders in terms of: Genetic inheritance (both autosomal recessive) Enzyme involvement Clinical onset and symptoms Long-term consequences if untreated Diagnostic tests: Ferric chloride test, urinary HGA detection, newborn screening programs Biochemical pathway: How a disruption in phenylalanine metabolism at different steps leads to distinct diseases